Home > Drug List > Resmetirom > News of Resmetirom

News of Resmetirom

Resmetirom was approved by the United States Food and Drug Administration(FDA) for the treatment of nonalcoholic steatohepatitis (NASH) on March 14,2024

This is the first FDA-approved treatment for NASH and marks an important milestone in the field.

Recommended Articles

Related Articles

There is no data under this category!
Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved